Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04965766
Status:
RECRUITING
Last Update Posted:
2023-05-18
First Post:
2021-06-03
Brief Title:
Patritumab Deruxtecan U3-1402 in Unresectable Locally Advanced or Metastatic Breast Cancer
Sponsor:
Organization:
Gustave Roussy Cancer Campus Grand Paris